CRISPR Therapeutics recently drew attention as updates highlighted progress in its gene-editing pipeline, including early-stage studies of CTX310, an in vivo therapy designed to lower LDL cholesterol ...
Arpita Bose and Zhecheng Zhang explore genetic tools in environmental microbes, citing applications in extracellular electron transfer ...
Programmable CRISPR tools are turning stem cell biology into something closer to software engineering, shrinking ...
Scientists in China have genetically engineered a fungus that is widely used as a meat substitute, making it an even more ...
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, has published new research in ...
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...
Both stocks are risky, but one is far less so. Investors seeking stocks with explosive growth potential should consider the ...
Seq, a CRISPR-based method that enriches ultra-rare tumor DNA in blood by removing background wild-type DNA before sequencing ...
Gene therapy could be a permanent cure for many life-threatening hereditary diseases, and this will only help in the treatment of genetic diseases and cancer ...
Chicago-based CRISPR technology company Syntax Bio says it has developed tech which automates the slow, manual process of ...
Scientists from Kolkata-based Bose Institute have created GlowCas9--a CRISPR protein that lights up while performing gene ...